BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S218-S219
- https://doi.org/10.1016/s0959-8049(01)81293-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: